Filing Details

Accession Number:
0001209191-11-017821
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-14 17:26:15
Reporting Period:
2011-03-10
Filing Date:
2011-03-14
Accepted Time:
2011-03-14 17:26:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267602 Alimera Sciences Inc ALIM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1489533 Daniel C. Myers 6120 Windward Parkway, Suite 290
Alpharetta GA 30005
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-03-10 55,147 $1.33 204,411 No 4 M Direct
Common Stock Disposition 2011-03-10 9,624 $7.66 194,787 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2011-03-10 55,147 $0.00 55,147 $1.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-01-01 No 4 M Direct
Footnotes
  1. Exercisable with respect to 1/4 of the shares of stock which are subject to this option on 11/22/06 (the "Initial Vesting Date"), provided Employee remains continuously employed by Alimera through the Initial Vesting Date; and 3/4 of the shares of stock which are subject to this option in equal increments quarterly over three years beginning on the date three (3) months from the Initial Vesting Date provided he or she remains continuously employed by Alimera through the last day of each quarterly period.